Metabolism
Metabolism inhibitors are compounds that interfere with metabolic pathways, altering the production and utilization of energy within cells. These inhibitors are used to study the regulation of metabolism, the role of metabolic pathways in diseases like cancer and diabetes, and to develop new therapeutic strategies. Metabolism inhibitors can target various enzymes and processes involved in glycolysis, fatty acid oxidation, and other metabolic functions. At CymitQuimica, we offer a wide range of high-quality metabolism inhibitors to support your research in biochemistry, metabolic disorders, and drug development.
Subcategories of "Metabolism"
- AhR(42 products)
- Aminopeptidase(76 products)
- CETP(20 products)
- Carbonic Anhydrase(196 products)
- Casein Kinase(139 products)
- DHFR(30 products)
- Decarboxylase(4 products)
- Dehydrogenase(302 products)
- FAAH(64 products)
- FXR(62 products)
- Factor Xa(87 products)
- Fatty Acid Synthase(37 products)
- Ferroptosis(227 products)
- GR(3 products)
- GSNOR(3 products)
- Glucokinase(56 products)
- HIF/HIF Prolyl-Hydroxylase(146 products)
- HMG-CoA Reductase(34 products)
- Hydroxylase(36 products)
- IDO(84 products)
- LDL(7 products)
- Lipase(107 products)
- Lipid(62 products)
- Lipoxygenase(133 products)
- MAO(85 products)
- MPO(2 products)
- NAMPT(40 products)
- P450(6 products)
- PAI-1(26 products)
- PDE(170 products)
- PED(1 products)
- PKM(17 products)
- PPAR(170 products)
- Phospholipase(85 products)
- ROR(47 products)
- Retinoid Receptor(18 products)
- SGK(10 products)
- Thioredoxin(12 products)
- Transferase(30 products)
- Transporter(43 products)
- UGT(4 products)
- Xanthine Oxidase (XO) Inhibitors(9 products)
Show 34 more subcategories
Found 9195 products of "Metabolism"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
EMD638683 R-Form
CAS:EMD638683 is a highly selective SGK1 inhibitor with IC50 of 3 μM. EMD638683 R-Form is the R-form of EMD638683.Formula:C18H18F2N2O4Color and Shape:SolidMolecular weight:364.34XL041
CAS:XL041 (BMS-852927) is an agonist of LXRβ-selective.Formula:C29H28Cl2F2N2O4SPurity:98%Color and Shape:SolidMolecular weight:609.51GTPγS tetralithium
CAS:GTPγS tetralithium (Guanosine 5'-[γ-thio]triphosphate tetralithium) is a G-protein activator and a non-hydrolyzable GTP analog.Formula:C10H12Li4N5O13P3SPurity:75%Color and Shape:SolidMolecular weight:562.984-epi Minocycline
CAS:4-epiMinocycline, recognized as a primary degradation product and a probable impurity in minocycline commercial formulations, is derived from minocycline, a broad-spectrum tetracycline antibiotic notable for its extended serum half-life. Besides treating acne, especially in older patients, minocylvania exhibits significant anti-inflammatory and neuroprotective effects.Formula:C23H27N3O7Color and Shape:SolidMolecular weight:457.48312(Z),15(Z)-Heneicosadienoic Acid
CAS:12(Z),15(Z)-Heneicosadienoic acid, an ω-6 very long-chain polyunsaturated fatty acid, serves as a positional isomer of heneicosadienoic acid, which is scarcely found in living organisms.Formula:C21H38O2Color and Shape:SolidMolecular weight:322.533MK-8666
CAS:MK-8666, a partial GPCR agonist targeting GPR40, may treat type 2 diabetes by enhancing insulin secretion and lowering glucose safely.Formula:C29H31NO6SColor and Shape:SolidMolecular weight:521.6211β-Prostaglandin F2α Ethanolamide
CAS:11β-Prostaglandin F2αethanolamide (11β-PGF2α-EA), posited as the hepatic metabolite derived from PGD2-EA during COX-2 metabolism of AEA—an endogenous cannabinoid present in brain, liver, and various mammalian tissues—is synthesized directly from AEA via COX-2 and specific prostaglandin synthase, leading to ethanolamide versions of classical prostaglandins. Additionally, PGD2-EA formation occurs in activated RAW 264.7 cells upon AEA treatment.Formula:C22H39NO5Color and Shape:SolidMolecular weight:397.61-Palmitoyl-sn-glycerol 3-phosphate
CAS:1-Palmitoyl-sn-glycerol 3-phosphate (1-P-GPA), an endogenous metabolite, is utilized in the research of non-alcoholic fatty liver disease [1].Formula:C19H39O7PColor and Shape:SolidMolecular weight:410.481,2-Dioleoyl-3-α-Linolenoyl-rac-glycerol
CAS:1,2-Dioleoyl-3-α-linolenoyl-rac-glycerol, a triacylglycerol, features oleic acid at the sn-1 and sn-2 positions and α-linolenic acid at the sn-3 position. This compound has been identified in the fat body of male B. lapidarius bumblebees.Formula:C57H100O6Color and Shape:SolidMolecular weight:881.4SCH-39370
CAS:SCH-39370 is a potent and specific neutral metalloendopeptidase (NEP) inhibitor.Formula:C22H26N2O6Color and Shape:SolidMolecular weight:414.45Flucythrinate
CAS:Flucythrinate is an insecticide.Formula:C26H23F2NO4Color and Shape:Viscous Liquid SolidMolecular weight:451.46(±)13,14-EDT
CAS:(±)13,14-EDT, an oxylipin metabolite derived from adrenic acid through the cytochrome P450 (CYP) pathway, acts as a potent activator of large-conductanceFormula:C22H36O3Color and Shape:SolidMolecular weight:348.5017(S)-HDoTE
CAS:17(S)-HDoTE, a metabolite of adrenic acid, is synthesized through the action of 15-lipoxygenase (15-LO) via a 17-HpDoTE intermediate.Formula:C22H36O3Color and Shape:SolidMolecular weight:348.521,2-Dilinoleoyl-3-α-Linolenoyl-rac-glycerol
CAS:1,2-Dilinoleoyl-3-α-linolenoyl-rac-glycerol is a triacylglycerol featuring linoleic acid at the sn-1 and sn-2 positions and α-linolenic acid at the sn-3 position, identified within corn and soybean oils.Formula:C57H96O6Color and Shape:SolidMolecular weight:877.37Δ2-trans-Hexadecenoic Acid
CAS:Cismonoenoic acids form readily from unsaturated fatty acids in animal tissues, with palmitoleic acid (9-cis-hexadecenoic acid) deriving from palmitic acid. An intermediate, 1Δ2-trans-hexadecenoic acid, arises during the β-oxidation of palmitic acid. Furthermore, Δ2-trans-hexadecenoic acid, at a dose of 10 mg/kg, significantly reduces gastric juice secretion in pylorus-ligated rats, indicating potential for gastric ulceration simulation models.Formula:C16H30O2Color and Shape:SolidMolecular weight:254.4O-Desmethyl Metoprolol
CAS:O-Desmethyl metoprolol, a metabolite of metoprolol, acts as a β1-adrenergic receptor (β1-AR) antagonist. This compound is produced through the metabolism of metoprolol by the cytochrome P450 (CYP) isoform CYP2D6.Formula:C14H23NO3Color and Shape:SolidMolecular weight:253.342GYKI-16084
CAS:GYKI-16084 is a postsynaptic alpha2 receptor blocker with potential efficacy in the treatment of benign prostatic hyperplasia.Formula:C16H19N3O3Color and Shape:SolidMolecular weight:301.342,3-dinor-8-iso Prostaglandin F1α
CAS:2,3-Dinor-8-iso Prostaglandin F1α (2,3-dinor-8-iso PGF1α), an isoprostane and active metabolite of arachidonic acid deriving its formation from non-enzymaticFormula:C18H32O5Color and Shape:SolidMolecular weight:328.40(±)11(12)-EpETE
CAS:Eicosapentaenoic acid (EPA) is metabolized into epoxyeicosatetraenoic acids (EpETE) by multiple cytochrome P450 isoforms. The predominant compound of this epoxygenase pathway, (±)17(18)-EpETE, induces relaxation in vascular and airway smooth muscles through its action on large conductance Ca2+-activated K+ (BKCa) channels, specifically by binding to the BKα channel subunits. Another notable epoxygenase pathway derivative, (±)11(12)-EpETE, also generated from EPA via CYP450 activity in both in vitro and in vivo studies, has biological and physiological roles that are yet to be fully elucidated.Formula:C20H30O3Color and Shape:SolidMolecular weight:318.5(+)-Carbovir
CAS:(+)-Carbovir is a nucleoside analog with increased chemical stability and increased metabolic stability.Formula:C11H13N5O2Color and Shape:SolidMolecular weight:247.25
